 treatment severe psoriasis acitretin results Canadian open multicenter study etretinate principal metabolite acitretin efficacious treatment psoriasis patients severe psoriasis chronic therapy study efficacy tolerability safety acitretin patients continuous treatment months initial daily dose mg weeks dose mg monthly intervals mg optimal response minimal toxicity Seventy percent patients months treatment marked improvement patients adverse reactions dry lips hair loss skin peeling pruritus nail disorders frequent Fourteen patients study intolerable adverse reactions